SLC18A2 and Parkinson disease: Decreased tissue concentrations of dopamine attenuated its uptake and transport functions altering dopamine turnover, thus VMAT2 levels correlate with the severity of Parkinsonism and (Hall et al. 2014) and cognitive impairment in DLB patients (Roselli et al. 2009).